News Focus
News Focus
Followers 258
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

Re: bramkers post# 73146

Friday, 10/10/2014 1:01:20 AM

Friday, October 10, 2014 1:01:20 AM

Post# of 405212
For a license with better than 30% on the back end and 75-100 million up front, 675 million would be about right with a well funded and well-connected big Pharma. of course, that would be just for B-ABSSSI. The other 4 would demand something similar. If you're talking about an outright purchase, well you can add at least one zero to 675 million and multiply by 5. 2to 3 billion is too little if B is what we all think it is. If Leo is full of bluster, then it's not even worth Durata, not that I think that for a moment. But B is somewhat binary: it's either all we believe and worthy of a 15 billion market cap with the first approval and 5 advanced trials, or it's worth almost nothing. The market playing the latter, I'm holding for the former plus the value of K.

“It is difficult to get a man to understand something, when his salary depends on his not understanding it.”
-- Upton Sinclair

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y